Trailing Twelve Months Revenue Growth: Biomerica, Inc. (BMRA)

Graphic logo of Biomerica Inc (BMRA)

Niche patent protection for GI tests provides Biomerica, Inc. (BMRA) with a moderate advantage. The current sales growth rate over a rolling 12-month period year-over-year illustrates revenue dynamics, where -11.20 serves as the final level marker. Automation of dosing lines ensures production efficiency. However, regulatory costs associated with implementing gastroenterology systems render the company's free cash flow unstable.

BMRA Biomerica, Inc. Sales Growth YoY (TTM) (02/11/2024 - 11/18/2026)

Biomerica Inc. (BMRA) - metric breakdowns and financial figures

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Summary company analytics:BMRA - Biomerica, Inc
Brand item of Biomerica

This indicator measures revenue dynamics over a rolling twelve-month period, neutralizing seasonality and market noise to determine the actual speed of business expansion. By analyzing the YoY revenue growth trend for TTM, an investor assesses the demand for Biomerica, Inc. (BMRA) diagnostic systems in clinics and pharmacies, where a steady ascent of the metric confirms the scaling of food intolerance test sales.

Who Biomerica, Inc. competes with

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|LAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cytekbio.com (CTKB)|OSUR (OraSure Corp) - Sales Growth YoY (TTM)|Exagen (XGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Prenetics PRE|Insight Molecular (IMDX) - Trailing Twelve Months Revenue Growth|Trinity Biotech Corp - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) ProPhase PRPH|AIMD: Sales Growth YoY (TTM)|CODX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Heart Test Laboratories, Inc.|CDIO (Cardio Diagnostics) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Onconetix Corp (ONCO)|VRAX (Virax Biolabs Group Limited) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)